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Medicinal plants have been documented over the years to play vital role in promoting human health. The study
evaluated the anti-inﬂammatory and anti-oxidant activities of different fractions and isolated compound from
Ricinodendron heudelotii leaves. The leaves of Ricinodendron heudelotii were extracted with ethanol and further
partitioned sequentially using petroleum ether, ethylacetate and butanol. Bioassay–guided fractionation of the
ethylacetate fraction was done using repeated column chromatographic technique while the structural elucidation
of pure compound was carried out using mass spectra, 13C and 1H NMR analyses. Antioxidant potential of the
fractions and isolated compound were evaluated with 2,2-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)
(ABTS) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assays and anti-inﬂammatory effect of
fractions was measured by their inhibitory potency on nitric oxide (NO).
Corilagin, an amorphous tannin was isolated and structurally elucidated. Corilagin showed scavenging effect
against ABTS and DPPH radicals which vary in a dose dependent manner. It also showed an antioxidant potential
with IC50 value of 0.003 mg/mL comparable to vitamin C 0.001 mg/mL) used as standard. The butanol and
ethylacetate fractions exhibited signiﬁcant (p < 0.05) NO inhibition of 60 and 69% respectively after treatment of
RAW 264.7 macrophages with lipopolysaccharide. These results demonstrated the role of isolated corilagin as a
promising potent antioxidant while the ethylacetate and butanol fractions suppressed the expression of an
inﬂammation mediator by inhibiting nitric oxide.1. Introduction
Medicinal plants contain diverse groups of phytochemicals. The
therapeutic and physiological effects of these phytochemicals make them
suitable for use in treating different diseases [1, 2]. The primary beneﬁt
of using medicinal plants and their derivatives is due to their availability
and affordability while still offering profound therapeutic beneﬁts. The
usage is also based on the belief that herbs might be more effective in
treating certain diseases [3]. The therapeutic potential of these plants are
linked to one or more compounds they contain which are termed phy-
tochemicals [4].
Ricinodendron heudelotii (family: Euphorbiaceae, genus Ricinoden-
dron), is commonly called the African oil-nut tree in English, “Okwe” and
“Erimado” in Igbo and Yoruba cultures of Nigeria respectively; theiversity.edu.ng (A.H. Adebayo), z
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vier Ltd. This is an open access aCameroonians call it “Njansang”. Different parts of the tree have been
used for treatments with the bark being the most frequently used and the
most efﬁcacious. The bark extract is used to cure cough and as antidote to
poison [5]. The roots are used as laxative and treatment of stomach pain
in Ghana and Nigeria [6]. The bark decoction is used to relieve in-
ﬂammations and it is equally employed as aphrodisiac. The bark is also
used to ease sexual, fertility, menstrual, childbirth pain [6]. The leaves
and latex are used to extract guinea worm and as a purgative. It is
commonly used in rural areas of Cameroon to prevent abortion. The bark
helps cure malaria, yellow fever, and dysentery and equally has diuretic
functions [7]. Recently, we reported the antimicrobial effect of
R. heudelotii extract [8] and the cytotoxic effect of isolated compounds
from the leaf extract [9]. It was also reported that the leaf extract
exhibited regulatory role on the toxicity of artemisinin whenhangyj@mail.kib.ac.cn (Y.-J. Zhang).
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are generated as a result of oxidative processes in the body. Some of them
include hydroxyl and hydrogen peroxide. Oxidative processes are un-
avoidable as they are important in energy metabolism and utilization of
nutrients [11]. Antioxidants help to scavenge free radicals and eliminate
them from the body system. Studies have shown a retroverted relation-
ship between disease progression and disease genesis and intake of
antioxidant rich foods [12]. Although synthetic antioxidants are avail-
able, they are out of reach of many due to high cost, reduced distribution
and side effects [13]. Natural antioxidants are however very much
available with minimal cost and showing little or no side effects. Com-
pounds high in antioxidant ability are ﬂavonoids and phenols. Trace el-
ements such as copper, manganese and magnesium also act as
antioxidants [14]. In small concentrations, ROS are important in the
human system as they help in gene expression, regulation of signal
transduction and other biological processes [11]. In high concentrations
however, ROS can have deleterious effects on biomolecules such as
proteins, lipids and other biomolecules and eventually cause cell death
[15]. An excess of ROS is also implicated in the genesis of many diseases
such as cancer and other age-related diseases including inﬂammation
[15]. Inﬂammation has been implicated in the genesis or progression of
most diseases and medicinal plants have recently been used as potent
anti-inﬂammatory therapy [16]. Inﬂammation is the body's immune
response to foreign substances as well as response to processes such as
degeneration and cell death. Inﬂammation is one of the innate immune
responses of the body [17]. Many diseases have been related to the
mechanism of oxidative stress and inﬂammation. It is therefore impor-
tant to explore the anti-inﬂammatory and antioxidant abilities of Rici-
nodendron heudelotii which could further add to existing knowledge on
the mode of action of the herbal plant.
2. Materials and methods
2.1. Reagents
2,2׳-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azino-bis-3-
ethylbenzothiazoline-6-sulfonic acid (ABTS), NG –Methyl-L-arginine ac-
etate salt, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
(Trolox), and ascorbic acid were purchased from Sigma Aldrich (USA).
Sephadex LH-20 (25–100 μm, GE Healthcare Bio-Science AB, Uppsala,
Sweden), MCI-gel CHP20P (75–150 μm, Mitsubishi Chemical Co, Ltd.,
Tokyo, Japan), silica gel H-precoated plates, 0.2–0,25 mm thick (Qing-
dao Haiyang Chemical Co., Qingdao, China).
2.2. Plant material
2.2.1. Plant collection
The leaves of Ricinodendron heudelotii were sourced within Covenant
University environ in Ota, Ogun State, Nigeria. The plant was identiﬁed
by Dr. J.O. Popoola (a Botanist in Biological Science Department of
Covenant University, Ota) and a voucher specimen was prepared and
submitted to the Forest Research Institute of Nigeria (FRIN), Ibadan with
voucher no FHI 110573. The leaves were allowed to dry at room tem-
perature (25 C) and blended using an electric blender into coarse
powder.
2.2.2. Preparation of plant extract
Extraction of the powdered leaf samples (5 kg) was done via the
maceration method using 95% ethanol, the mixture was ﬁltered and the
ﬁltrate further condensed under reduced pressure and temperature and
the yield of the extract obtained was 11.75%. The concentrated crude
extract (0.5 kg) was suspended in 1 L distilled water and partitioned in
sequence with petroleum ether (Pet; 8 L), ethylacetate (EtOAc; 8 L) and
n-butanol (8 L). The solvent fractions were concentrated to dryness to
afford four (4) fractions as: Pet, EtOAc, n-butanol and Water fractions.
The EtOAc fraction was selected for subsequent isolation procedures2[18].
2.3. Isolation of compound from the partitioned fraction
The ethylacetate fraction (246 g) was loaded into a column contain-
ing Sephadex LH 20 gel (300 g, 100–200mesh). The eluent was a mixture
of water and methanol in different ratio starting with 100:1. Fractions
with similar thin layer chromatography (TLC) patterns were combined to
obtain 13 fractions. Fraction 11 (36 g) was chromatographed on a
Sephadex LH 20 gel column and then MCI gel by eluting with water:-
methanol (4:1) to obtain corilagin (12 mg).
2.4. Anti-inﬂammatory activity
Nitric oxide (NO) production from RAW 264.7 macrophages was
assessed by measuring accumulation of nitrite in the supernatant after
treatment with lipopolysaccharide (LPS) for 24 h with or without the
extracts using Griess reagent in a method described by Reif and
McCreedy [19]. The experiments were done in triplicates.
2.4.1. Cell culture
RAW 264.7 murine macrophage cells were cultured in Dulbecco's
Modiﬁed Eagle Media (DMEM) supplemented with 10% foetal bovine
serum, streptomycin (100 μg/mL) and penicillin (100 U/mL) in a 5%
atmosphere of CO2 at 37 C. Viability of the cells were evaluated via the
MTS assay simultaneously.
2.4.2. Procedure
The RAW 264.7 macrophages were seeded into 96 well-microliter
plates at a depth of 2 x 104 cells per well. The cells were left overnight
to allow them attach properly and then incubated in a medium of LPS (5
μg/mL) (negative control); the compounds were serially diluted up to a
maximum concentration of 25 μM in triplicate. After incubation period of
24 h, 100 μL of the supernatant from each well were transferred into new
plates containing Griess reagent of equal volume. Absorbance was
recorded at 570 nm on a micro plate reader using nitric oxide synthase
(NOS) inhibitor, as the positive control (NG-Methyl-L-arginine acetate
salt (L-NMMA) [19]. Percentage NO inhibition was derived based on
each sample's ability to inhibit the production of nitric oxide by RAW
264.7 macrophages when compared with the cells treated with LPS only.
2.5. Antioxidant assays
2.5.1. DPPH radical scavenging activity assay
The antioxidant potential of the fractions and isolated compound on
1,1- diphenyl-2-picrylhydrazyl (DPPH) was determined following pre-
viously described method by Liu et al. [20]. Methanolic DPPH solution
(100 μM, 100 μL) were added to samples of different concentration
(1–1000 μg/mL, 100 μL). The mixture was left to stand at room tem-
perature for 15 min and thereafter the absorbance values were read at
517 nm using ascorbic acid as positive control. Six serial dilutions of
samples were further prepared and following the above procedure, the
absorbance of each sample concentration against a blank was recorded
using a microspectrophotometer (Spectra Max 340, California, USA). The
radical scavenging activity of DPPH was calculated using the equation
below:
DPPH reduction (%) ¼ 100 x [Ablank – Asample]/Ablank
Assay was carried out in triplicates and a plot of percentage DPPH
reduction and sample concentration was drawn (correlation coefﬁcient
R2 ¼ 0.99–1). Antioxidant activity was expressed as inhibitory concen-
tration (IC50) values.
2.5.2. ABTS radical scavenging activity
The 2.20-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid (ABTS)
Table 1
Percentage Inhibition of extract of R. heudelotii on Nitric oxide production.
Conc % Inhibition
L-NAME 50 μM 31.11  0.40
Crude extract 40 μg/mL 52.45  1.07
Ethylacetate fraction 40 μg/mL 69.03  1.54*
Water fraction 40 μg/mL 30.29  0.91
Butanol Fraction 40 μg/mL 60.66  1.25*
* L-NAME: N omega-nitro-L-arginine methyl ester.
*signiﬁcant (p < 0.05) when compared with the control.
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by Re et al. [21]. The working reagent was prepared by dissolving 7 mM
ABTS and 2.45 mM potassium persulphate (1:1) in distilled water. The
mixture was left in the dark at room temperature for 12–16 h. After
which 3 mL of the working reagent was diluted with 150 mL of methanol
to obtain an absorbance of 0.700 at 734 nm. The diluted reagent (1 mL)
was then added to the sample of varying concentrations (0.2–1.0 mg/mL)
and left in the dark to react and the absorbance was measured at 734 nm
after 30 min. The assay was done in triplicates using trolox as standard.
Percentage inhibition was calculated as follows:
% ABTS scavenging ¼ ((Abscontrol-Abssample)/Abscontrol) x 100
where Abscontrol is absorbance of ABTSþ þ methanol, Abssample is
absorbance of ABTS þ methanol.
2.6. Statistical analysis
Samples are expressed as mean  standard error of mean. The values
were compared with control group and p values <0.05 were considered
signiﬁcantly different
3. Results
3.1. Structure elucidation of isolated compound
The compoundwas obtained as a yellow amorphous powder, showing
a molecular ion peak at m/z 633 [M] in the negative ESI-MS. From 1H-,
13C-NMR, and DEPT spectroscopic data, the molecular formula of
C27H22O18 was deduced. Comparing the data with those in the literature,
it was identiﬁed as corilagin (Fig. 1) [22].
3.2. Spectroscopic data of isolated compound
Corilagin: Yellow amorphous powder, C27H22O18, negative ESI-MS
m/z 633 [M  H], 1H-NMR (600, CD3OD): δH 7.05 (2H, s, H-20,60),
6.69, 6.65 (each 1H, s, HHDP-300,3000), 6.36 (1H, d, J ¼ 2.4 Hz, H-1), 4.95
(1H, ddd, J¼ 10.9, 8.0, 1.2 Hz, H-6a), 4.80 (1H, brs, H-3), 4.51 (1H, t, J¼
9.6 Hz, H-5), 4.46 (1H, dd, J ¼ 1.7, 1.2 Hz, H-4), 4.16 (1H, dd, J ¼ 8.0,
10.9 Hz, H-6b), 3.98 (1H, brd, J ¼ 1.2 Hz, H-2); 13C-NMR (150 MHz,
CD3OD): HHDP δC 167.1 and 167.6 (C¼O), 145.8, 145.1 (C-300, 3000),
144.9, 144.3 (C-500,5000), 136.3, 136.2 (C-400, 4000), 116.2, 116.1 (C-100, 1000),
124.1, 123.8 (C-200, 2000), 107.3, 106.7 (C-600, 6000); galloyl δC 165.2 (C¼O),
146.2 (C-30, C-50), 139.7 (C-40), 119.4 (C-10), 109.7 (C-20, C-6’); glucose
δC 92.9 (C- 1), 78.3 (C-3), 76.6 (C-5), 72.4 (C-2), 64.2 (C-6), 62.8 (C-4).Fig. 1. Structure of corilagin isolated from R. heudelotii.
33.3. Inhibition of nitric oxide production by R. heudelotii
The effects of the fractions of R. heudelotii extract on the nitric oxide
production in the macrophage cells were evaluated 24 h after cells were
treated with 1 μg/mL of LPS and 40 μg/mL of the fractions of R. heudelotii.
As reported in Table 1, the ethylacetate fraction signiﬁcantly decreased
the production of nitric oxide. We can infer from this study that
R. heudelotii can inhibit production of nitric oxide in RAW 264.7 mac-
rophages when stimulated with LPS.
3.4. In vitro antioxidant assessment of isolated compound and fractions of
R. heudelotii
The in vitro antioxidant activity of the butanol and ethylacetate
fractions were highly comparable with vitamin C (Fig. 2).
The antioxidant activity of corilagin isolated from R. heudelotii was
slightly higher than that of the standard used; vitamin C for DPPH
(Fig. 3a) and trolox for ABTS (Fig. 3b) assay. The result also showed that
it is concentration dependent (Fig 3a and b). In both methods, corilagin
















Fig. 3. IC50 values of ABTS activities of corilagin from R. heudelotii.
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Fig. 2. IC50 values of DPPH radical scavenging activity of extracts and com-
pound from R. heudelotii.
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Free radicals like H2O2 and NO produced during inﬂammation can
result in cell damage and vasodilation which can lead to chronic
inﬂammation; thus placing much importance on a potent anti-
inﬂammatory agent. This study evaluated the anti-inﬂammatory effect
of different fractions of R. heudelotii in activated RAW264.7macrophages
as well as antioxidant activity of the fractions and isolated compound,
corilagin on DPPH and ABTS dyes.
Nitric oxide is considered to mediate inﬂammatory reactions due to
it’s over production in diseased conditions [23] and can contribute to
chronic inﬂammatory disease of the gut, joints and lungs. Hence NO
inhibitors could serve as a therapeutic measure in managing inﬂamma-
tory diseases [23, 24].
In this current study, the ethylacetate and butanol fractions
exhibited signiﬁcant (p < 0.05) NO inhibition after treating the RAW
264.7 macrophages with LPS. The ethylacetate fraction showed the
highest percentage inhibition of 69 while the butanol fraction
exhibited 60% inhibition when compared with the control (NG-Methyl-
L-arginine acetate salt) (Table 1). The NO inhibitory effect of the
ethylacetate fraction may help arrest series of reactions originated as a
result of excess peroxynitrite generation which is deleterious to health,
thus can be employed as a potential ameliorative agent for inﬂam-
mation [14].
The qualitative phytochemical screening of the butanol and ethyl-
acetate fractions of R. heudelotii revealed the presence of tannins, ﬂavo-
noids amongst others as reported by Yakubu et al. [8]. This might
account for the antiinﬂammatory potential of these two fractions. This
correlates with the ﬁndings of Ahmadiani et al. [25] which showed that
tannins and ﬂavonoids exhibit anti-inﬂammatory effects. The water
fraction was less effective in NO inhibition and this could be due to
absence of tannins.
From our study, the isolated corilagin was obtained from the
ethylacetate fraction of R. heudelotii. The presence of corilagin, a
tannin could have played a crucial role in the NO inhibitory effect as
seen in Table 1 [26]. Corilagin has also been shown to lower
pro-inﬂammatory cytokines and mediators such as iNOS and TNF-α
by blocking the NF-kb pathway in macrophage cell lines stimulated
by lipopolysaccharide (LPS) [27, 28]. It also reduced the effect of N9
murine cells injury induced by tert-butyl hydroperoxide (TBHP)
[29].
In addition, we observed that the butanol and ethylacetate fraction
including the isolated compound had highly comparable antioxidant
effect on two different oxidant dyes (ABTS and DPPH) when compared
with trolox and ascorbic acid which were standards for ABTS and
DPPH respectively (Figs. 2 and 3). Measurement of the antioxidant
activity via DPPH and/or superoxide scavenging activities has been
reported to have a linear correlation with such plant's phenolic content
[30, 31]. This implies that the high antioxidant activity displayed by
the ethylacetate and butanol fractions could be as a result of phenolic
components present in each of the fractions. Also the possibility of
multiple phenolic compounds in the ethylacetate fraction working
together to scavenge DPPH cannot be ignored. The antioxidant activity
of corilagin isolated from R. heudelotii; a phenolic tannin, was observed
to be slightly higher than Vitamin C, the standard control used for this
study; the result also showed that it is concentration dependent
(Fig. 3). The high activities of the compound could be linked to the
high level of reactivity of its hydroxyl group as Jayant et al. [32] re-
ported that antioxidant activity can increase with increased number of
hydroxyl groups. This is in accordance with the study carried out by
Chen and Chen [29] where they suggested corilagin as a candidate for
treating neurodegenerative diseases by attenuating oxidative stress
injury induced by tert-butyl hydroperoxide in microglial cells. The
anti-tumor potential of corilagin has also been reported by Hau et al.
[33] in vivo in hepatocellular carcinoma (Hep3B) due to its antioxidant
potential.45. Conclusion
As seen in Fig. 1, corilagin has a large number of hydroxyl groups;
hence we can conclude that our results demonstrated the role of isolated
corilagin as a promising potent antioxidant while the ethylacetate frac-
tion and butanol fractions suppressed the expression of an inﬂammation
mediator by inhibiting nitric oxide. Further studies might be conducted
to explore the possible mode of action of corilagin in interacting with the
oxidative and inﬂammatory pathways in animal and cell models.
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